Discrepancies in Composition and Biological Effects of Different Formulations of Chondroitin Sulfate

Osteoarthritis is a common, progressive joint disease, and treatments generally aim for symptomatic improvement. However, SYmptomatic Slow-Acting Drugs in Osteoarthritis (SYSADOAs) not only reduce joint pain, but slow structural disease progression. One such agent is chondroitin sulfate—a complex, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Martel-Pelletier, Johanne, Farran, Aina, Montell, Eulàlia, Vergés, Josep, Pelletier, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272499/
https://www.ncbi.nlm.nih.gov/pubmed/25756648
http://dx.doi.org/10.3390/molecules20034277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272499/
https://www.ncbi.nlm.nih.gov/pubmed/25756648
http://dx.doi.org/10.3390/molecules20034277

Ejemplares similares